| Ticker Details |
Alphatec Holdings, Inc.
Alphatec Holdings Inc is a medical technology company. It is engaged in the design, development and promotion of products for the surgical treatment of spine disorders. Its product portfolio includes Biolocs, cervical, interbody, and others.
|
| IPO Date: |
June 2, 2006 |
| Sector: |
Healthcare |
| Industry: |
Health Care Equipment and Supplies |
| Market Cap: |
$1.46B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.18 | 3.32%
|
| Avg Daily Range (30 D): |
$0.28 | 3.01%
|
| Avg Daily Range (90 D): |
$0.32 | 3.54%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.53M |
| Avg Daily Volume (30 D): |
1.79M |
| Avg Daily Volume (90 D): |
2.66M |
| Trade Size |
| Avg Trade Size (Sh.): |
113 |
| Avg Trade Size (Sh.) (30 D): |
74 |
| Avg Trade Size (Sh.) (90 D): |
93 |
| Institutional Trades |
| Total Institutional Trades: |
3,072 |
| Avg Institutional Trade: |
$1.93M |
| Avg Institutional Trade (30 D): |
$1.96M |
| Avg Institutional Trade (90 D): |
$1.99M |
| Avg Institutional Trade Volume: |
.16M |
| Avg Institutional Trades (Per Day): |
2 |
| Market Closing Trades |
| Avg Closing Trade: |
$2.35M |
| Avg Closing Trade (30 D): |
$2.7M |
| Avg Closing Trade (90 D): |
$3.37M |
| Avg Closing Volume: |
193.66K |
|
|
| Financials |
| |
TTM |
Q2 2026 |
Q1 2026 |
|
Basic EPS
|
|
$-.16
|
$-.22
|
|
Diluted EPS
|
|
$-.16
|
$-.22
|
|
Revenue
|
|
$213.51M
|
$192.11M
|
|
Gross Profit
|
|
$154.1M
|
$136.48M
|
|
Net Income / Loss
|
|
$-25.78M
|
$-33.91M
|
|
Operating Income / Loss
|
|
$-1.91M
|
$-22.58M
|
|
Cost of Revenue
|
|
$59.42M
|
$55.63M
|
|
Net Cash Flow
|
|
$-21.73M
|
$-20.38M
|
|
PE Ratio
|
|
|
|
|
|
|